1. Home
  2. FCO vs NMTC Comparison

FCO vs NMTC Comparison

Compare FCO & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo abrdn Global Income Fund Inc.

FCO

abrdn Global Income Fund Inc.

HOLD

Current Price

$3.01

Market Cap

41.4M

Sector

Finance

ML Signal

HOLD

Logo NeuroOne Medical Technologies Corporation

NMTC

NeuroOne Medical Technologies Corporation

HOLD

Current Price

$0.77

Market Cap

39.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCO
NMTC
Founded
N/A
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.4M
39.5M
IPO Year
1994
2010

Fundamental Metrics

Financial Performance
Metric
FCO
NMTC
Price
$3.01
$0.77
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$1.98
AVG Volume (30 Days)
149.2K
163.5K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.43
EPS
N/A
N/A
Revenue
N/A
$9,097,692.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$31.90
P/E Ratio
N/A
N/A
Revenue Growth
N/A
163.47
52 Week Low
$2.73
$0.40
52 Week High
$6.77
$1.15

Technical Indicators

Market Signals
Indicator
FCO
NMTC
Relative Strength Index (RSI) 42.20 51.55
Support Level $2.98 $0.69
Resistance Level $3.06 $0.91
Average True Range (ATR) 0.10 0.05
MACD -0.01 0.00
Stochastic Oscillator 21.43 34.83

Price Performance

Historical Comparison
FCO
NMTC

About FCO abrdn Global Income Fund Inc.

abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories: Developed Markets, Investment Grade Developing Markets, and Sub-Investment Grade Developing Markets.

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

Share on Social Networks: